|
1
|
Brechbiel J, Miller-Moslin K and Adjei AA:
Crosstalk between hedgehog and other signaling pathways as a basis
for combination therapies in cancer. Cancer Treat Rev. 40:750–759.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xie J, Bartels CM, Barton SW and Gu D:
Targeting hedgehog signaling in cancer: Research and clinical
developments. Onco Targets Ther. 6:1425–1435. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen F, Cheng L, Douglas AE, Riobo NA and
Manning DR: Smoothened is a fully competent activator of the
heterotrimeric G protein G(i). Mol Pharmacol. 83:691–697. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fernández-Zapico ME: Primers on molecular
pathways GLI: More than just Hedgehog? Pancreatology. 8:227–229.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stecca B and Ruiz I Altaba A:
Context-dependent regulation of the GLI code in cancer by HEDGEHOG
and non-HEDGEHOG signals. J Mol Cell Biol. 2:84–95. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kasper M, Regl G, Frischauf AM and Aberger
F: GLI transcription factors: Mediators of oncogenic Hedgehog
signalling. Eur J Cancer. 42:437–445. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lipinski RJ, Gipp JJ, Zhang J, Doles JD
and Bushman W: Unique and complimentary activities of the Gli
transcription factors in Hedgehog signaling. Exp Cell Res.
312:1925–1938. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nozawa YI, Lin C and Chuang PT: Hedgehog
signaling from the primary cilium to the nucleus: An emerging
picture of ciliary localization, trafficking and transduction. Curr
Opin Genet Dev. 23:429–437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Briscoe J and Thérond PP: The mechanisms
of Hedgehog signalling and its roles in development and disease.
Nat Rev Mol Cell Biol. 14:416–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hui CC and Angers S: Gli proteins in
development and disease. Annu Rev Cell Dev Biol. 27:513–537. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dennler S, André J, Alexaki I, Li A,
Magnaldo T, ten Dijke P, Wang XJ, Verrecchia F and Mauviel A:
Induction of sonic hedgehog mediators by transforming growth
factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression
in vitro and in vivo. Cancer Res. 67:6981–6986. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ji Z, Mei FC, Xie J and Cheng X: Oncogenic
KRAS activates hedgehog signaling pathway in pancreatic cancer
cells. J Biol Chem. 282:14048–14055. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stecca B, Mas C, Clement V, Zbinden M,
Correa R, Piguet V, Beermann F and Ruiz I Altaba A: Melanomas
require HEDGEHOG-GLI signaling regulated by interactions between
GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA.
104:5895–5900. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noubissi FK, Goswami S, Sanek NA, Kawakami
K, Minamoto T, Moser A, Grinblat Y and Spiegelman VS: Wnt signaling
stimulates transcriptional outcome of the Hedgehog pathway by
stabilizing GLI1 mRNA. Cancer Res. 69:8572–8578. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoon JW, Gallant M, Lamm ML, Iannaccone S,
Vieux KF, Proytcheva M, Hyjek E, Iannaccone P and Walterhouse D:
Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in
Burkitt lymphoma. Mol Cancer Res. 11:604–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pasca di Magliano M and Hebrok M: Hedgehog
signalling in cancer formation and maintenance. Nat Rev Cancer.
3:903–911. 2003. View
Article : Google Scholar
|
|
17
|
Kwon YJ, Hurst DR, Steg AD, Yuan K, Vaidya
KS, Welch DR and Frost AR: Gli1 enhances migration and invasion via
up-regulation of MMP-11 and promotes metastasis in ERα negative
breast cancer cell lines. Clin Exp Metastasis. 28:437–449. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abidi A: Hedgehog signaling pathway: a
novel target for cancer therapy: vismodegib, a promising
therapeutic option in treatment of basal cell carcinomas. Indian J
Pharmacol. 46:3–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sekulic A, Migden MR, Oro AE, Dirix L,
Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander
PA, et al: Efficacy and safety of vismodegib in advanced basal-cell
carcinoma. N Engl J Med. 366:2171–2179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hassounah NB, Bunch TA and McDermott KM:
Molecular pathways: The role of primary cilia in cancer progression
and therapeutics with a focus on Hedgehog signaling. Clin Cancer
Res. 18:2429–2435. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han YG, Kim HJ, Dlugosz AA, Ellison DW,
Gilbertson RJ and Alvarez-Buylla A: Dual and opposing roles of
primary cilia in medulloblastoma development. Nat Med.
15:1062–1065. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yuan K, Serra R and Frost AR: Primary
cilia in the breast and breast cancer. Open Breast Cancer J.
2:101–107. 2010.
|
|
23
|
Sadlonova A, Novak Z, Johnson MR, Bowe DB,
Gault SR, Page GP, Thottassery JV, Welch DR and Frost AR: Breast
fibroblasts modulate epithelial cell proliferation in
three-dimensional in vitro co-culture. Breast Cancer Res.
7:R46–R59. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Steg A, Wang W, Blanquicett C, Grunda JM,
Eltoum IA, Wang K, Buchsbaum DJ, Vickers SM, Russo S, Diasio RB, et
al: Multiple gene expression analyses in paraffin-embedded tissues
by TaqMan low-density array: Application to hedgehog and Wnt
pathway analysis in ovarian endometrioid adenocarcinoma. J Mol
Diagn. 8:76–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Berbari NF, O’Connor AK, Haycraft CJ and
Yoder BK: The primary cilium as a complex signaling center. Curr
Biol. 19:R526–R535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yuan K, Frolova N, Xie Y, Wang D, Cook L,
Kwon YJ, Steg AD, Serra R and Frost AR: Primary cilia are decreased
in breast cancer: Analysis of a collection of human breast cancer
cell lines and tissues. J Histochem Cytochem. 58:857–870. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Egeberg DL, Lethan M, Manguso R, Schneider
L, Awan A, Jørgensen TS, Byskov AG, Pedersen LB and Christensen ST:
Primary cilia and aberrant cell signaling in epithelial ovarian
cancer. Cilia. 1:152012. View Article : Google Scholar
|
|
28
|
Menzl I, Lebeau L, Pandey R, Hassounah NB,
Li FW, Nagle R, Weihs K and McDermott KM: Loss of primary cilia
occurs early in breast cancer development. Cilia. 3:72014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nobutani K, Shimono Y, Yoshida M, Mizutani
K, Minami A, Kono S, Mukohara T, Yamasaki T, Itoh T, Takao S, et
al: Absence of primary cilia in cell cycle-arrested human breast
cancer cells. Genes Cells. 19:141–152. 2014. View Article : Google Scholar
|
|
30
|
Kruk PA and Auersperg N: Human ovarian
surface epithelial cells are capable of physically restructuring
extracellular matrix. Am J Obstet Gynecol. 167:1437–1443. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nielsen SK, Møllgård K, Clement CA, Veland
IR, Awan A, Yoder BK, Novak I and Christensen ST: Characterization
of primary cilia and Hedgehog signaling during development of the
human pancreas and in human pancreatic duct cancer cell lines. Dev
Dyn. 237:2039–2052. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lewis MT and Veltmaat JM: Next stop, the
twilight zone: Hedgehog network regulation of mammary gland
development. J Mammary Gland Biol Neoplasia. 9:165–181. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen JK, Taipale J, Young KE, Maiti T and
Beachy PA: Small molecule modulation of Smoothened activity. Proc
Natl Acad Sci USA. 99:14071–14076. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mukherjee S, Frolova N, Sadlonova A, Novak
Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson
MR, et al: Hedgehog signaling and response to cyclopamine differ in
epithelial and stromal cells in benign breast and breast cancer.
Cancer Biol Ther. 5:674–683. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Harrington N, Moraes RC, Wu MF,
Hilsenbeck SG and Lewis MT: Cyclopamine inhibition of human breast
cancer cell growth independent of Smoothened (Smo). Breast Cancer
Res Treat. 115:505–521. 2009. View Article : Google Scholar
|
|
36
|
Meyers-Needham M, Lewis JA, Gencer S,
Sentelle RD, Saddoughi SA, Clarke CJ, Hannun YA, Norell H, da Palma
TM, Nishimura M, et al: Off-target function of the Sonic hedgehog
inhibitor cyclopamine in mediating apoptosis via nitric
oxide-dependent neutral sphingomyelinase 2/ceramide induction. Mol
Cancer Ther. 11:1092–1102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Taipale J, Chen JK, Cooper MK, Wang B,
Mann RK, Milenkovic L, Scott MP and Beachy PA: Effects of oncogenic
mutations in Smoothened and Patched can be reversed by cyclopamine.
Nature. 406:1005–1009. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Y, Arvanites AC, Davidow L, Blanchard
J, Lam K, Yoo JW, Coy S, Rubin LL and McMahon AP: Selective
identification of hedgehog pathway antagonists by direct analysis
of smoothened ciliary translocation. ACS Chem Biol. 7:1040–1048.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kiprilov EN, Awan A, Desprat R, Velho M,
Clement CA, Byskov AG, Andersen CY, Satir P, Bouhassira EE,
Christensen ST, et al: Human embryonic stem cells in culture
possess primary cilia with hedgehog signaling machinery. J Cell
Biol. 180:897–904. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wong SY, Seol AD, So PL, Ermilov AN,
Bichakjian CK, Epstein EH Jr, Dlugosz AA and Reiter JF: Primary
cilia can both mediate and suppress Hedgehog pathway-dependent
tumorigenesis. Nat Med. 15:1055–1061. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hassounah NB, Nagle R, Saboda K, Roe DJ,
Dalkin BL and McDermott KM: Primary cilia are lost in preinvasive
and invasive prostate cancer. PLoS One. 8:e685212013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Emoto K, Masugi Y, Yamazaki K, Effendi K,
Tsujikawa H, Tanabe M, Kitagawa Y and Sakamoto M: Presence of
primary cilia in cancer cells correlates with prognosis of
pancreatic ductal adenocarcinoma. Hum Pathol. 45:817–825. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
LoRusso PM, Rudin CM, Reddy JC, Tibes R,
Weiss GJ, Borad MJ, Hann CL, Brahmer JR, Chang I, Darbonne WC, et
al: Phase I trial of hedgehog pathway inhibitor vismodegib
(GDC-0449) in patients with refractory, locally advanced or
metastatic solid tumors. Clin Cancer Res. 17:2502–2511. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Amakye D, Jagani Z and Dorsch M:
Unraveling the therapeutic potential of the Hedgehog pathway in
cancer. Nat Med. 19:1410–1422. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tang JY, Mackay-Wiggan JM, Aszterbaum M,
Yauch RL, Lindgren J, Chang K, Coppola C, Chanana AM, Marji J,
Bickers DR, et al: Inhibiting the hedgehog pathway in patients with
the basal-cell nevus syndrome. N Engl J Med. 366:2180–2188. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Von Hoff DD, LoRusso PM, Rudin CM, Reddy
JC, Yauch RL, Tibes R, Weiss GJ, Borad MJ, Hann CL, Brahmer JR, et
al: Inhibition of the hedgehog pathway in advanced basal-cell
carcinoma. N Engl J Med. 361:1164–1172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang Y, Zhou Z, Walsh CT and McMahon AP:
Selective translocation of intracellular Smoothened to the primary
cilium in response to Hedgehog pathway modulation. Proc Natl Acad
Sci USA. 106:2623–2628. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Barakat B, Yu L, Lo C, Vu D, De Luca E,
Cain JE, Martelotto LG, Dedhar S, Sadler AJ, Wang D, et al:
Interaction of smoothened with integrin-linked kinase in primary
cilia mediates Hedgehog signalling. EMBO Rep. 14:837–844. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tian H, Callahan CA, DuPree KJ, Darbonne
WC, Ahn CP, Scales SJ and de Sauvage FJ: Hedgehog signaling is
restricted to the stromal compartment during pancreatic
carcinogenesis. Proc Natl Acad Sci USA. 106:4254–4259. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yauch RL, Gould SE, Scales SJ, Tang T,
Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, et al: A
paracrine requirement for hedgehog signalling in cancer. Nature.
455:406–410. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Feldmann G, Habbe N, Dhara S, Bisht S,
Alvarez H, Fendrich V, Beaty R, Mullendore M, Karikari C, Bardeesy
N, et al: Hedgehog inhibition prolongs survival in a genetically
engineered mouse model of pancreatic cancer. Gut. 57:1420–1430.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Banerjee U and Hadden MK: Recent advances
in the design of Hedgehog pathway inhibitors for the treatment of
malignancies. Expert Opin Drug Discov. 9:751–771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lee JJ, Perera RM, Wang H, Wu DC, Liu XS,
Han S, Fitamant J, Jones PD, Ghanta KS, Kawano S, et al: Stromal
response to Hedgehog signaling restrains pancreatic cancer
progression. Proc Natl Acad Sci USA. 111:E3091–E3100. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Epstein EH: Basal cell carcinomas: Attack
of the hedgehog. Nat Rev Cancer. 8:743–754. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chenna V, Hu C, Pramanik D, Aftab BT,
Karikari C, Campbell NR, Hong SM, Zhao M, Rudek MA, Khan SR, et al:
A polymeric nanoparticle encapsulated small-molecule inhibitor of
Hedgehog signaling (NanoHHI) bypasses secondary mutational
resistance to Smoothened antagonists. Mol Cancer Ther. 11:165–173.
2012. View Article : Google Scholar :
|
|
56
|
Lauth M, Bergström A, Shimokawa T and
Toftgård R: Inhibition of GLI-mediated transcription and tumor cell
growth by small-molecule antagonists. Proc Natl Acad Sci USA.
104:8455–8460. 2007. View Article : Google Scholar : PubMed/NCBI
|
